Se. Pedersen, SITE-SELECTIVE PHOTOAFFINITY-LABELING OF THE TORPEDO-CALIFORNICA NICOTINIC ACETYLCHOLINE-RECEPTOR BY AZIDE DERIVATIVES OF ETHIDIUM-BROMIDE, Molecular pharmacology, 47(1), 1995, pp. 1-9
Three azido derivatives of ethidium bromide, a potent noncompetitive a
ntagonist of the nicotinic acetylcholine receptor from Torpedo califor
nica, were synthesized, namely 8-azido-ethidium chloride, 3-azido-ethi
dium chloride, and 3,8-diazido-ethidium chloride. These derivatives we
re tested for their ability to interact with the noncompetitive antago
nist binding site and the acetylcholine binding sites on the acetylcho
line receptor. The derivatives bound to the noncompetitive antagonist
site with 2-5-fold lower affinity than did ethidium bromide, as determ
ined by competitive inhibition of [H-3]phencyclidine binding, indicati
ng a moderate effect of the azide groups upon binding. Inhibition of [
H-3]-acetylcholine binding by ethidium and its azide derivatives indic
ated differential binding to the two agonist sites, with high affinity
binding to the same site that exhibits high affinity for d-tubocurain
e. Photoaffinity labeling by these derivatives revealed reaction with
the alpha and gamma subunits that was specific for the acetylcholine b
inding sites. Inhibition of labeling by d-tubocurarine showed reaction
with alpha subunits at both of the acetylcholine binding sites, where
as reaction with the gamma subunit was consistent with reaction only a
t the site with high affinity for d-tubocuraine. There was no correspo
nding reaction with the delta subunit, which forms part of the second
acetylcholine binding site, despite reaction with the apposing alpha s
ubunit. The azides, therefore, display preferential reaction with the
gamma subunit. The selectivity of the reaction must reflect structural
differences between the two sites, and subsequent determination of th
e labeled site(s) should reveal the nature of the differences.